Torresan Sara, Zussino Gaia, Cortiula Francesco, Follador Alessandro, Fasola Gianpiero, Girometti Rossano, Cereser Lorenzo
Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), 33100 Udine, Italy.
Department of Medicine (DAME), University of Udine, 33100 Udine, Italy.
J Clin Med. 2023 Feb 6;12(4):1266. doi: 10.3390/jcm12041266.
Radiation recall pneumonitis (RRP) is a rare inflammatory reaction that occurs in previously irradiated fields, and it may be caused by various triggering agents. Immunotherapy has been reported to potentially be one of these triggers. However, precise mechanisms and specific treatments have not been explored yet due to a lack of data in this setting. Here, we report a case of a patient who received radiation therapy and immune checkpoint inhibitor therapy for non-small cell lung cancer. He developed first radiation recall pneumonitis and subsequently immune-checkpoint inhibitor-induced pneumonitis (IIP). After presenting the case, we discuss the currently available literature on RRP and the challenges of differential diagnosis between RRP, IIP, and other forms of pneumonitis. We believe that this case is of particular clinical value since it highlights the importance of including RRP in a differential diagnosis of lung consolidation during immunotherapy. Furthermore, it suggests that RRP might anticipate more extensive ICI-induced pneumonitis.
放射性肺炎(RRP)是一种罕见的炎症反应,发生在先前接受过放疗的区域,可能由多种触发因素引起。据报道,免疫治疗可能是其中一种触发因素。然而,由于在这种情况下缺乏数据,精确的机制和具体治疗方法尚未得到探索。在此,我们报告一例接受非小细胞肺癌放疗和免疫检查点抑制剂治疗的患者。他首先发生了放射性肺炎,随后出现了免疫检查点抑制剂诱导的肺炎(IIP)。在介绍该病例后,我们讨论了目前关于RRP的文献以及RRP、IIP和其他形式肺炎鉴别诊断的挑战。我们认为该病例具有特殊的临床价值,因为它突出了在免疫治疗期间将RRP纳入肺实变鉴别诊断的重要性。此外,这表明RRP可能预示着更广泛的ICI诱导的肺炎。